Novartis
NVS
NVS
874 hedge funds and large institutions have $22.5B invested in Novartis in 2014 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 314 increasing their positions, 335 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
2% more capital invested
Capital invested by funds: $22B → $22.5B (+$520M)
0.06% less ownership
Funds ownership: 9.79% → 9.72% (-0.06%)
6% less repeat investments, than reductions
Existing positions increased: 314 | Existing positions reduced: 335
Holders
874
Holding in Top 10
71
Calls
$187M
Puts
$110M
Top Buyers
| 1 | +$222M | |
| 2 | +$40.1M | |
| 3 | +$38M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$34.6M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$30.7M |
Top Sellers
| 1 | -$151M | |
| 2 | -$80.1M | |
| 3 | -$72.2M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$67.2M |
| 5 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$60.2M |